These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

786 related articles for article (PubMed ID: 23768554)

  • 1. Diabetes, obesity and gut microbiota.
    Everard A; Cani PD
    Best Pract Res Clin Gastroenterol; 2013 Feb; 27(1):73-83. PubMed ID: 23768554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota controls adipose tissue expansion, gut barrier and glucose metabolism: novel insights into molecular targets and interventions using prebiotics.
    Geurts L; Neyrinck AM; Delzenne NM; Knauf C; Cani PD
    Benef Microbes; 2014 Mar; 5(1):3-17. PubMed ID: 23886976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of gut microbiota in the pathogenesis of obesity and diabetes].
    Stachowicz N; Kiersztan A
    Postepy Hig Med Dosw (Online); 2013 Apr; 67():288-303. PubMed ID: 23619228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutrition, the gut microbiome and the metabolic syndrome.
    Kovatcheva-Datchary P; Arora T
    Best Pract Res Clin Gastroenterol; 2013 Feb; 27(1):59-72. PubMed ID: 23768553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome.
    Delzenne NM; Neyrinck AM; Cani PD
    Microb Cell Fact; 2011 Aug; 10 Suppl 1(Suppl 1):S10. PubMed ID: 21995448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbiota as a Therapeutic Target for Metabolic Disorders.
    Okubo H; Nakatsu Y; Kushiyama A; Yamamotoya T; Matsunaga Y; Inoue MK; Fujishiro M; Sakoda H; Ohno H; Yoneda M; Ono H; Asano T
    Curr Med Chem; 2018; 25(9):984-1001. PubMed ID: 28990516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential interest of gut microbial changes induced by non-digestible carbohydrates of wheat in the management of obesity and related disorders.
    Neyrinck AM; Delzenne NM
    Curr Opin Clin Nutr Metab Care; 2010 Nov; 13(6):722-8. PubMed ID: 20823777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus.
    Kootte RS; Vrieze A; Holleman F; Dallinga-Thie GM; Zoetendal EG; de Vos WM; Groen AK; Hoekstra JB; Stroes ES; Nieuwdorp M
    Diabetes Obes Metab; 2012 Feb; 14(2):112-20. PubMed ID: 21812894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?
    Diamant M; Blaak EE; de Vos WM
    Obes Rev; 2011 Apr; 12(4):272-81. PubMed ID: 20804522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between the gut microbiota and the endocannabinoid system: impact on the gut barrier function and the adipose tissue.
    Cani PD
    Clin Microbiol Infect; 2012 Jul; 18 Suppl 4():50-3. PubMed ID: 22647050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gut microbiome as therapeutic target.
    Cani PD; Delzenne NM
    Pharmacol Ther; 2011 May; 130(2):202-12. PubMed ID: 21295072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity.
    Cani PD; Osto M; Geurts L; Everard A
    Gut Microbes; 2012; 3(4):279-88. PubMed ID: 22572877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
    Esteve E; Ricart W; Fernández-Real JM
    Curr Opin Clin Nutr Metab Care; 2011 Sep; 14(5):483-90. PubMed ID: 21681087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.
    Miele L; Giorgio V; Alberelli MA; De Candia E; Gasbarrini A; Grieco A
    Curr Cardiol Rep; 2015 Dec; 17(12):120. PubMed ID: 26497040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting gut microbiota in obesity: effects of prebiotics and probiotics.
    Delzenne NM; Neyrinck AM; Bäckhed F; Cani PD
    Nat Rev Endocrinol; 2011 Aug; 7(11):639-46. PubMed ID: 21826100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota and type 2 diabetes mellitus.
    Muñoz-Garach A; Diaz-Perdigones C; Tinahones FJ
    Endocrinol Nutr; 2016 Dec; 63(10):560-568. PubMed ID: 27633134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity.
    Tai N; Wong FS; Wen L
    Rev Endocr Metab Disord; 2015 Mar; 16(1):55-65. PubMed ID: 25619480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota and obesity.
    Krznarić Z; Vranešić Bender D; Kunović A; Kekez D; Stimac D
    Dig Dis; 2012; 30(2):196-200. PubMed ID: 22722438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury.
    Frazier TH; DiBaise JK; McClain CJ
    JPEN J Parenter Enteral Nutr; 2011 Sep; 35(5 Suppl):14S-20S. PubMed ID: 21807932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota and the development of obesity.
    Boroni Moreira AP; Fiche Salles Teixeira T; do C Gouveia Peluzio M; de Cássia Gonçalves Alfenas R
    Nutr Hosp; 2012; 27(5):1408-14. PubMed ID: 23478685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.